Zacks Research Upgrades Nu Skin Enterprises (NYSE:NUS) to Hold

Nu Skin Enterprises (NYSE:NUS) was upgraded by investment analysts at Zacks Research from a “strong sell” rating to a “hold” rating in a report released on Monday, Zacks reports.

Separately, Weiss Ratings cut shares of Nu Skin Enterprises from a “sell (d+)” rating to a “sell (d)” rating in a report on Tuesday, August 11th. One analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Reduce”.

Nu Skin Enterprises Price Performance

NYSE NUS opened at $5.01 on Monday. The company has a quick ratio of 1.24, a current ratio of 1.98 and a debt-to-equity ratio of 0.36. The stock has a market capitalization of $244.13 million, a PE ratio of -1.12 and a beta of 0.91. Nu Skin Enterprises has a 12-month low of $4.45 and a 12-month high of $11.67. The company has a 50 day moving average price of $4.78 and a two-hundred day moving average price of $5.62.

Nu Skin Enterprises (NYSE:NUS) last announced its quarterly earnings results on Monday, August 10th. The company reported $0.20 EPS for the quarter, hitting the consensus estimate of $0.20. The company had revenue of $320.11 million for the quarter, compared to analyst estimates of $345.20 million. Nu Skin Enterprises had a negative net margin of 15.73% and a positive return on equity of 6.58%. Nu Skin Enterprises has set its FY 2026 guidance at 0.700-0.900 EPS and its Q3 2026 guidance at 0.100-0.200 EPS. As a group, equities analysts predict that Nu Skin Enterprises will post 0.82 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Nu Skin Enterprises

Large investors have recently made changes to their positions in the business. Dimensional Fund Advisors LP boosted its stake in Nu Skin Enterprises by 26.3% during the 1st quarter. Dimensional Fund Advisors LP now owns 1,735,182 shares of the company’s stock valued at $12,632,000 after purchasing an additional 361,810 shares during the period. CastleKnight Management LP increased its position in Nu Skin Enterprises by 3.1% in the 4th quarter. CastleKnight Management LP now owns 844,733 shares of the company’s stock worth $8,126,000 after buying an additional 25,200 shares during the period. Lazard Asset Management LLC increased its position in Nu Skin Enterprises by 88.0% in the 1st quarter. Lazard Asset Management LLC now owns 330,647 shares of the company’s stock worth $2,407,000 after buying an additional 154,814 shares during the period. Empowered Funds LLC lifted its holdings in shares of Nu Skin Enterprises by 16.9% during the first quarter. Empowered Funds LLC now owns 282,398 shares of the company’s stock worth $2,056,000 after buying an additional 40,728 shares during the last quarter. Finally, Ritholtz Wealth Management lifted its holdings in shares of Nu Skin Enterprises by 18.0% during the first quarter. Ritholtz Wealth Management now owns 179,249 shares of the company’s stock worth $1,305,000 after buying an additional 27,281 shares during the last quarter. Institutional investors and hedge funds own 82.84% of the company’s stock.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc (NYSE:NUS) is a global direct-selling company that develops and markets personal care, beauty and wellness products. Its portfolio includes skincare products, nutritional supplements and beauty devices sold under brands such as Nu Skin, ageLOC and Pharmanex.

The company distributes its products primarily through a network of independent sales representatives, supported by digital commerce and other direct-selling channels. Nu Skin serves customers across markets in the Americas, Asia-Pacific, Europe, Africa and the Middle East, with product offerings and operations varying by region.

Founded in 1984 and headquartered in Provo, Utah, Nu Skin has built its business around research-supported skincare and nutritional products, including anti-aging and wellness-focused offerings.